[go: up one dir, main page]

NO20033801L - Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser - Google Patents

Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser

Info

Publication number
NO20033801L
NO20033801L NO20033801A NO20033801A NO20033801L NO 20033801 L NO20033801 L NO 20033801L NO 20033801 A NO20033801 A NO 20033801A NO 20033801 A NO20033801 A NO 20033801A NO 20033801 L NO20033801 L NO 20033801L
Authority
NO
Norway
Prior art keywords
group
psychotic disorders
phenyl
prevention
treatment
Prior art date
Application number
NO20033801A
Other languages
English (en)
Other versions
NO20033801D0 (no
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20033801D0 publication Critical patent/NO20033801D0/no
Publication of NO20033801L publication Critical patent/NO20033801L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfinnelse er rettet mot en fremgangsmåte for å hindre eller behandle psykotiske forstyrrelser som innbefatter administrering til et subjekt som trenger det en terapeutisk effektiv mengde av forbindelser utvalgt fra gruppen som består av formel (I) og formel (II) hvori fenyl er substituert i X med en til fem halogenatomer utvalgt fra gruppen som består av fluor, klor, brom og jodd, og, Ri, R, R3, R4, Rog Re er uavhengig utvalgt fra gruppen som består av hydrogen og C-Calkyl, hvori C-Calkyl eventuelt er substituert med fenyl (hvori fenyl eventuelt er substituert med substituenter utavhengig utvalgt fra gruppen som består av halogen, C-Calkyl, C-Calkoksy, amino, nitro og cyano).
NO20033801A 2001-02-27 2003-08-26 Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser NO20033801L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (2)

Publication Number Publication Date
NO20033801D0 NO20033801D0 (no) 2003-08-26
NO20033801L true NO20033801L (no) 2003-10-22

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033801A NO20033801L (no) 2001-02-27 2003-08-26 Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser

Country Status (25)

Country Link
US (1) US6541513B2 (no)
EP (1) EP1401424B1 (no)
JP (1) JP4276841B2 (no)
KR (1) KR100886578B1 (no)
CN (1) CN1262271C (no)
AR (1) AR032876A1 (no)
AT (1) ATE346597T1 (no)
AU (1) AU2002242296B2 (no)
BR (1) BR0207829A (no)
CA (1) CA2439480C (no)
CZ (1) CZ302412B6 (no)
DE (1) DE60216457T2 (no)
DK (1) DK1401424T3 (no)
ES (1) ES2275844T3 (no)
HU (1) HUP0303342A3 (no)
IL (2) IL157588A0 (no)
MX (1) MXPA03007722A (no)
NO (1) NO20033801L (no)
NZ (1) NZ527991A (no)
PL (1) PL365021A1 (no)
PT (1) PT1401424E (no)
RS (1) RS51056B (no)
RU (1) RU2302240C2 (no)
TW (1) TWI251486B (no)
WO (1) WO2002067927A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002007822A2 (en) * 2000-07-21 2002-01-31 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
CA2439295C (en) * 2001-02-27 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
BR0207830A (pt) * 2001-02-27 2004-06-22 Ortho Mcneil Pharm Inc Compostos de carbamato para uso em prevenir ou tratar distúrbios de ansiedade
RU2303445C2 (ru) 2001-07-16 2007-07-27 Орто-Макнейл Фармасьютикал, Инк. Карбаматные соединения для применения для предотвращения или лечения невропатической боли и боли, связанной с кластерной и мигреневой головной болью
WO2005107719A2 (en) * 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
CN101272776B (zh) * 2005-07-26 2012-10-03 詹森药业有限公司 氨基甲酸酯在制备治疗物质滥用相关疾病药物中的用途
EA200970436A1 (ru) * 2006-10-30 2009-12-30 Янссен Фармацевтика, Н.В. Соединения карбамата для лечения депрессии
EP2089011A1 (en) * 2006-10-31 2009-08-19 Janssen Pharmaceutica N.V. Treatment of pervasive developmental disorders
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
EP2968210B1 (en) 2013-03-12 2024-09-11 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating pediatric epilesy
CN105164103B (zh) * 2013-03-12 2019-12-06 比皮艾思药物研发有限公司 苯基氨基甲酸酯化合物和含有其的预防或治疗记忆缺失相关疾病的组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
KR0167346B1 (ko) * 1989-06-09 1999-01-15 로버트 에이. 아미테이지 중추신경계 활성을 갖는 헤테로사이클릭 아민
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
CN1505507A (zh) 2004-06-16
MXPA03007722A (es) 2004-11-12
CZ302412B6 (cs) 2011-05-04
HUP0303342A3 (en) 2012-07-30
RS51056B (sr) 2010-10-31
ES2275844T3 (es) 2007-06-16
PL365021A1 (en) 2004-12-27
IL157588A (en) 2009-12-24
IL157588A0 (en) 2004-03-28
DK1401424T3 (da) 2007-02-26
KR100886578B1 (ko) 2009-03-05
CN1262271C (zh) 2006-07-05
US20020165272A1 (en) 2002-11-07
NO20033801D0 (no) 2003-08-26
TWI251486B (en) 2006-03-21
PT1401424E (pt) 2007-02-28
RU2003128983A (ru) 2005-03-10
JP2004523556A (ja) 2004-08-05
JP4276841B2 (ja) 2009-06-10
DE60216457T2 (de) 2007-09-20
CZ20032297A3 (cs) 2004-06-16
HUP0303342A2 (hu) 2004-01-28
DE60216457D1 (de) 2007-01-11
CA2439480A1 (en) 2002-09-06
CA2439480C (en) 2011-04-26
BR0207829A (pt) 2004-06-22
RU2302240C2 (ru) 2007-07-10
RS67503A (sr) 2006-12-15
KR20030076713A (ko) 2003-09-26
ATE346597T1 (de) 2006-12-15
NZ527991A (en) 2005-04-29
US6541513B2 (en) 2003-04-01
WO2002067927A1 (en) 2002-09-06
AU2002242296B2 (en) 2006-06-29
AR032876A1 (es) 2003-11-26
EP1401424A1 (en) 2004-03-31
EP1401424B1 (en) 2006-11-29

Similar Documents

Publication Publication Date Title
CY1106924T1 (el) Ενωσεις καρβαμικου για χρηση οσον αφορα την προληψη ή την αγωγη των διαταραχων κινησης
CY1111349T1 (el) Καρβαμιδικες ενωσεις προς χρηση στη θεραπεια του πονου
NO20080877L (no) Fremgangsmater for behandling av substansrelaterte forstyrrelser
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
NO20033801L (no) Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser
NO20072444L (no) Karbamatforbindelser for anvendelse i behandling av neurodegenerative forstyrrelser
NO20033802L (no) Karbamatforbindelser for anvendelse ved forebygging eller behandling av bipolar forstyrrelse
NO20033799L (no) Karbamatforbindelser for anvendelse ved prevensjon eller terapi av bipolarelidelser
DK1399144T3 (da) Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
NO20040176L (no) Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte
BR0211240A (pt) Compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada à cefaléia em cacho e hemicrânia
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders
MY149385A (en) Methods for treating substance-related disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application